Inflammation as a risk factor for myocardial infarction

Area of Science:

• Genetics
• Immunology
• Cardiovascular Disease

Background:

• Myocardial infarction (MI) pathogenesis involves genetic factors.
• Understanding the genetic basis of MI is crucial for clinical heterogeneity.
• Inflammation plays a role in vascular processes relevant to MI.

Purpose of the Study:

• To identify genetic factors associated with myocardial infarction (MI).
• To investigate the role of lymphotoxin-alpha (LTA) and galectin-2 in MI pathogenesis.
• To explore the interplay between genetic variations, inflammation, and MI risk.

Main Methods:

• Case-control association study using gene-based single nucleotide polymorphism (SNP) sets.
• Genotyping approximately 65,000 SNPs using multiplex PCR and Invader methods.
• Identifying protein-protein interactions and analyzing genetic associations with gene expression and protein secretion.

Main Results:

• Two SNPs within the lymphotoxin-alpha (LTA) gene were significantly associated with MI risk.
• LTA protein was identified to interact with galectin-2 protein.
• An SNP in the LGALS2 gene (encoding galectin-2) was also associated with MI susceptibility, affecting LTA secretion.

Conclusions:

• The LTA cascade and inflammation are critical in myocardial infarction pathogenesis.
• Genetic variations in LTA and LGALS2 influence MI risk through inflammatory pathways.
• A combined genetic and molecular approach is valuable for understanding common disease pathogenesis.